$AMPH Income Statement | Understand Stock

$AMPH

$25.57 +$0.10 (0.39%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Product
Other
Total revenues
Cost of revenues
Gross profit
Operating expenses:
Selling, distribution, and marketing
General and administrative
Research and development
Total operating expenses
Income from operations
Non-operating income (expenses):
Interest income
Interest expense
Other income (expenses), net
Total non-operating income (expenses), net
Income before income taxes
Income tax provision
Income before equity in losses of unconsolidated affiliate
Equity in losses of unconsolidated affiliates
Net income attributable to Amphastar Pharmaceuticals, Inc.
Net income attributable to non-controlling interests
Net income
Net income per share:
Basic
Diluted
Weighted-average shares used to compute net income per share:
Basic (in shares)
Diluted (in Shares)

Comments